what is retatrutide made from How works: mechanism of action and onset explained Retatrutide: The New Triple-Agonist Weight
Description
GLP-1 helps your pancreas release insulin in response to elevated blood sugar, but only when your glucose levels are high
These compounds share similar pharmacokinetics and safety profiles, while effectively improving glycemic control and potentially offering additional benefits for cardiovascular health
When starting GLP-1/GIP, youll begin with a 2.5mg starter dose for the first 4 weeks
Access this article Similar content being viewed by others References Feigin VL, Abajobir AA, Abate KH, Abd-Allah F, Abdulle AM, Abera SF, et al
Bydureon: Summary of product characteristics
Rare serious adverse events: Pancreatitis, gallbladder disease, acute kidney injury
